| [1] |
Chesdachai S, Katz B, Sapkota S. Diagnostic Challenges and Dilemmas in Tuberculous Meningitis. Am J Med Sci, 2020, 359(6): 372-377. doi:10.1016/j.amjms.2020.03.010.
|
| [2] |
Mason S, Solomons R. CSF Metabolomics of Tuberculous Meningitis: A Review. Metabolites, 2021, 11(10): 661. doi:10.3390/metabo11100661.
|
| [3] |
Soria J, Metcalf T, Mori N, et al. Mortality in hospitalized patients with tuberculous meningitis. BMC Infect Dis, 2019, 19(1): 9. doi:10.1186/s12879-018-3633-4.
|
| [4] |
WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment (2020 update). Geneva: World Health Organization, 2020.
|
| [5] |
Kempker RR, Smith AGC, Avaliani T, et al. Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness. Clin Infect Dis, 2022, 75(4): 682-689. doi:10.1093/cid/ciab992.
|
| [6] |
Fang MT, Su YF, An HR, et al. Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China. BMC Infect Dis, 2021, 21(1): 1015. doi:10.1186/s12879-021-06705-4.
|
| [7] |
Maranchick NF, Alshaer MH, Smith AGC, et al. Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis. Front Pharmacol, 2022, 13: 1048653. doi:10.3389/fphar.2022.1048653.
|
| [8] |
Madadi AK, Sohn MJ. Comprehensive Therapeutic Appro-aches to Tuberculous Meningitis: Pharmacokinetics, Combined Dosing, and Advanced Intrathecal Therapies. Pharmaceutics, 2024, 16(4): 540. doi:10.3390/pharmaceutics16040540.
|
| [9] |
Wang W, Gao J, Liu J, et al. Clinical Efficacy of Dexamethasone in the Treatment of Patients with Tuberculous Meningitis: A Meta-Analysis. Contrast Media Mol Imaging, 2022, 2022: 2180374. doi:10.1155/2022/2180374.
|
| [10] |
Zhang X, Li P, Wen J, et al. Ventriculoperitoneal shunt for tuberculous meningitis-associated hydrocephalus: long-term outcomes and complications. BMC Infect Dis, 2023, 23(1): 742. doi:10.1186/s12879-023-08661-7.
|
| [11] |
Singh H, Patir R, Vaishya S, et al. External ventricular drain related complications-whether continuous csf drainage via ommaya reservoir is the answer?. Neurol India, 2020, 68(2): 458-461. doi:10.4103/0028-3886.284354.
|
| [12] |
Donovan J, Figaji A, Imran D, et al. The neurocritical care of tuberculous meningitis. Lancet Neurol, 2019, 18(8): 771-783. doi:10.1016/S1474-4422(19)30154-1.
|
| [13] |
Dian S, Ganiem AR, Te Brake LH, et al. Current Insights into Diagnosing and Treating Neurotuberculosis in Adults. CNS Drugs, 2023, 37(11): 957-972. doi:10.1007/s40263-023-01047-y.
|
京公安网备11010202008787号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
